Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

NIOSHTIC-2 Publications Search

Search Results

Investigation of protein expression in magnetic field-treated human glioma cells.

Authors
Kanitz-MH; Witzmann-FA; Lotz-WG; Conover-D; Savage-RE Jr.
Source
Bioelectromagnetics 2007 Oct; 28(7):546-552
NIOSHTIC No.
20032810
Abstract
We previously reported phenotypic changes in human breast cancer cells following low-level magnetic field (MF) exposure. Here proteomic methods were used to investigate the biochemical effect of MF exposure in SF767 human glioma cells. Protein alterations were studied after exposure to 1.2 microTesla (T) MF [12 milliGauss (mG), 60 Hertz (Hz)] epidermal growth factor (EGF). SF767 cells were exposed for 3 h to sham conditions (<0.2 T ambient field strength) or 1.2 T MF (EGF; 10 ng/ml). Solubilized protein fractions (sham; 1.2 T; sham + EGF; 1.2 T + EGF) were loaded for electrophoresis by 2D-PAGE and stained using a colloidal Coomassie blue technique to resolve and characterize the proteins. Protein patterns were compared across groups via Student's t-test using PDQUEST software. Cell profiles revealed significant alterations in the spot density of a subset of treated cells. Automated spot excision and processing was performed prior to peptide mass fingerprinting proteins of interest. Fifty-seven proteins from the detectable pool were identified and/or found to differ significantly across treatment groups. The mean abundance of 10 identified proteins was altered following 1.2 T exposure. In the presence of EGF six proteins were altered after low magnetic field treatment by increasing (4) or decreasing (2) in abundance. The results suggest that the analysis of differentially expressed proteins in SF767 cells may be useful as biomarkers for biological changes caused by exposure to magnetic fields.
Keywords
Genes; Proteins; Genetic-factors; Exposure-levels; Carcinogens; Carcinogenicity; Carcinogenesis; Magnetic-fields; Cell-function; Biomarkers
Contact
M.H. Kanitz, MGMT, BHAB, DART, NIOSH, 4676 Columbia Parkway, MS/C-23, Cincinnati, OH 45226-1998
CODEN
BLCTDO
Publication Date
20071001
Document Type
Journal Article
Email Address
mhk2@cdc.gov
Fiscal Year
2008
NTIS Accession No.
NTIS Price
Issue of Publication
7
ISSN
0197-8462
NIOSH Division
DART
Priority Area
Research Tools and Approaches: Exposure Assessment Methods
Source Name
Bioelectromagnetics
State
OH; IN
TOP